Premium
Aptevo Therapeutics Inc (APVO)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.2505 | -21.7100694444 | 5.76 | 5.9492 | 3.65 | 415852 | 4.11630569 | CS |
| 4 | -5.9208 | -56.7653854635 | 10.4303 | 14.9 | 3.65 | 1388605 | 9.02257654 | CS |
| 12 | -2.1505 | -32.2897897898 | 6.66 | 19.055 | 3.65 | 6773469 | 10.46240576 | CS |
| 26 | -17.2835 | -79.3075758271 | 21.793 | 24.2683 | 3.65 | 6414497 | 14.97574352 | CS |
| 52 | -302.0429 | -98.5289627483 | 306.5524 | 399.6 | 3.65 | 3579106 | 23.81338054 | CS |
| 156 | -12563.6505 | -99.9641196484 | 12568.16 | 13918.586 | 3.65 | 1373494 | 609.27093455 | CS |
| 260 | -938.4281 | -99.5217605067 | 942.9376 | 97680 | 3.65 | 1176029 | 7444.183446 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
